{"id":24581,"date":"2021-08-25T11:37:08","date_gmt":"2021-08-25T09:37:08","guid":{"rendered":"https:\/\/ellipse.prbb.org\/?p=24581"},"modified":"2021-08-25T11:37:09","modified_gmt":"2021-08-25T09:37:09","slug":"els-anticossos-contra-el-sars-cov-2-es-mantenen-fins-a-set-mesos-despres-de-la-infeccio","status":"publish","type":"post","link":"https:\/\/ellipse.prbb.org\/ca\/els-anticossos-contra-el-sars-cov-2-es-mantenen-fins-a-set-mesos-despres-de-la-infeccio\/","title":{"rendered":"Els anticossos contra el SARS-CoV-2 es mantenen fins a set mesos despr\u00e9s de la infecci\u00f3"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">En la pand\u00e8mia de la COVID-19, la <strong>ci\u00e8ncia<\/strong> ha hagut de fer mans i m\u00e0nigues per <strong>donar resposta a les grans inc\u00f2gnites<\/strong> que envolten aquesta malaltia <strong>en el menor temps possible. <\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Una de les q\u00fcestions que m\u00e9s preocupa \u00e9s <strong>saber si la resposta del sistema immunitari t\u00e9 caducitat<\/strong>. Per aix\u00f2 \u00e9s especialment rellevant l&#8217;estudi liderat per la <strong>Carlota Doba\u00f1o<\/strong> i la <strong>Gemma Moncunill<\/strong> de l&#8217;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.isglobal.org\/en\/\" target=\"_blank\">Institut de Salut Global de Barcelona (ISGlobal)<\/a>, que analitza la pres\u00e8ncia d&#8217;<strong><a rel=\"noreferrer noopener\" href=\"https:\/\/www.isglobal.org\/ca\/-\/los-anticuerpos-frente-al-sars-cov-2-se-mantienen-estables-o-incluso-aumentan-7-meses-despues-de-la-infeccion\" target=\"_blank\">anticossos contra el virus del SARS-CoV-2<\/a><\/strong>, fins a <strong>set mesos despr\u00e9s de la infecci\u00f3<\/strong>. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Per a poder estudiar la <strong>resposta immunit\u00e0ria de llarga durada<\/strong>, l&#8217;equip ha estudiat la <strong>pres\u00e8ncia d&#8217;anticossos IgA, IgM i IgG contra sis ant\u00edgens presents en el SARS-CoV- 2<\/strong> aix\u00ed com contra el <strong>coronavirus del refredat com\u00fa<\/strong> en una cohort de <strong>personal sanitari<\/strong> de l&#8217;Hospital Cl\u00ednic &#8211; un dels col\u00b7lectius m\u00e9s exposats a la malaltia de manera primerenca. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Els resultats de l&#8217;estudi mostren que: <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>La majoria de les infeccions del personal sanitari, que van afectar a un de cada set treballadors, es van donar durant la primera onada de la pand\u00e8mia. <\/li><li><strong>Els anticossos contra fragments del SARS-CoV-2 es mantenen estables<\/strong>, o fins i tot incrementen, fins a <strong>set mesos despr\u00e9s de la infecci\u00f3<\/strong>.<\/li><li>Els<strong> anticossos<\/strong> contra el coronavirus del <strong>refredat com\u00fa<\/strong> podrien conferir una <strong>immunitat creuada<\/strong> contra la malaltia de la <strong>COVID-19<\/strong>.<\/li><\/ul>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">En aquest estudi tamb\u00e9 hi ha participat la <a href=\"https:\/\/www.crg.eu\/en\/programmes-groups\/protein-technologies-unit#unit_members\" target=\"_blank\" rel=\"noreferrer noopener\">unitat de tecnologia de prote\u00efnes<\/a> del <a rel=\"noreferrer noopener\" href=\"http:\/\/www.crg.eu\/\" target=\"_blank\">Centre de Regulaci\u00f3 Gen\u00f2mica (CRG)<\/a>, produint prote\u00efnes o fragments proteics usats com a ant\u00edgens.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;estudi de seroprevalen\u00e7a de diversos anticossos contra el virus del SARS-CoV-2 determina que la resposta immunit\u00e0ria \u00e9s de llarga durada. <\/p>\n","protected":false},"author":26,"featured_media":24582,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[721,265,411,295],"new-type":[35],"class_list":["post-24581","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recerca","tag-coronavirus-ca","tag-crg-ca","tag-immunologia","tag-isglobal-cat","new-type-noticies"],"acf":[],"_links":{"self":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/24581","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/comments?post=24581"}],"version-history":[{"count":9,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/24581\/revisions"}],"predecessor-version":[{"id":24610,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/24581\/revisions\/24610"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media\/24582"}],"wp:attachment":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media?parent=24581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/categories?post=24581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/tags?post=24581"},{"taxonomy":"new-type","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/new-type?post=24581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}